Sabby Management’s Evoke Pharma EVOK Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q1 | – | Sell |
-611
| Closed | -$48K | – | 101 |
|
2021
Q4 | $48K | Buy |
611
+42
| +7% | +$3.3K | 0.01% | 96 |
|
2021
Q3 | $107K | Buy |
569
+240
| +73% | +$45.1K | 0.01% | 84 |
|
2021
Q2 | $65K | Buy |
+329
| New | +$65K | 0.01% | 83 |
|
2021
Q1 | – | Sell |
-451
| Closed | -$168K | – | 98 |
|
2020
Q4 | $168K | Buy |
451
+296
| +191% | +$110K | 0.03% | 45 |
|
2020
Q3 | $105K | Buy |
+155
| New | +$105K | 0.02% | 60 |
|
2016
Q4 | – | Sell |
-443
| Closed | -$144K | – | 171 |
|
2016
Q3 | $144K | Buy |
+443
| New | +$144K | 0.01% | 132 |
|